Please assess the completion status of the following clinical trial:

Trial Title: Antepartum Betamethasone Treatment for Prevention of Respiratory Distress in Infants Born by Elective Cesarean Section

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Pregnant women \>/= 34 weeks gestation scheduled to undergo operative delivery within 48-72 hours after study enrollment~Exclusion Criteria:~* Known contraindication to the use of betamethasone in the mother~* Known lethal or non-lethal congenital anomaly diagnosed antenatally~* Spontaneous labor~* Premature rupture of membranes

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Betamethasone (Type: EXPERIMENTAL): Betamethasone injection
- Placebo (Type: PLACEBO_COMPARATOR): Placebo injection

Based on this trial design, predict the completion outcome and termination type (if applicable).